Review
Nature Reviews Neuroscience 9, 437-452 (June 2008) | doi:10.1038/nrn2392
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
Lin Mei1 & Wen-Cheng Xiong1 About the authors
Abstract
Schizophrenia is a highly debilitating mental disorder that affects 
1% of the general population, yet it continues to be poorly understood. Recent studies have identified variations in several genes that are associated with this disorder in diverse populations, including those that encode neuregulin 1 (NRG1) and its receptor ErbB4. The past few years have witnessed exciting progress in our knowledge of NRG1 and ErbB4 functions and the biological basis of the increased risk for schizophrenia that is potentially conferred by polymorphisms in the two genes. An improved understanding of the mechanisms by which altered function of NRG1 and ErbB4 contributes to schizophrenia might eventually lead to the development of more effective therapeutics.
- View At a Glance
Author affiliations
- Program of Developmental Neurobiology, Institute of Molecular Medicine and Genetics, Department of Neurology, Medical College of Georgia, Augusta, Georgia 30912, USA.
Correspondence to: Lin Mei1 Email: lmei@mcg.edu
Published online 14 May 2008
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Inhibitory synapses turn excitingNature Neuroscience News and Views (01 Mar 2005)
Get stoned in GABAergic synapsesNature Neuroscience News and Views (01 Sep 2009)
See all 4 matches for News And ViewsRESEARCH
Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphismsMolecular Psychiatry Original Article
See all 47 matches for Research
